Initiatives towards psychedelic policy reform are taking place in Europe, from a conference on psychedelic-assisted therapies at the European Parliament...
Compared to other psychedelic conferences, ECNP was a dose of European realism - from the anticipated effect sizes of psychedelic trials to the cut and...
The article Oregon Issues First Psilocybin Licenses. Now What? was originally published on Microdose. This article originally appeared on the Harris Bricken...
The study is expected to cost C$2.7 million and will run for three months. The post Cantheon Provides Funding to Albert Labs for Psilocybin Drug Development...
An unusual coalition, including an Illinois state legislator and a local Psychedelic Society, has created the proposed CURE Act to legalize psilocybin...
The article PharmaTher Announces Positive FDA Meeting; Path Towards Phase 3 Trial was originally published on Microdose. PharmaTher continues to move...
The article Atai CEO Answers Questions From the Public was originally published on Microdose. Reddit is the internet incarnate. From time-wasting memes,...
In an effort to raise funding for commercialization of MDMA-assisted therapy, MAPS partnered with an investment bank to sell equity in its Public Benefit...
A study at Imperial College London examined the effects of DMT (dimethyltryptamine), a potent psychedelic compound, on brain function using detailed brain...
Hello, friends, and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single package. Daily Crunch:...